Prim6 vs Recurpal: Revenue, Funding & Team Size Compared
Prim6 generates $47.4K in revenue; Recurpal generates $45.3K. Prim6 and Recurpal are close to the same size by revenue. The table below compares Prim6 and Recurpal on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $47.4K | $45.3K |
| Valuation | $711.5K | Not disclosed |
| Funding raised | $180K | Not disclosed |
| Team size | 2 | 1 |
| Founded | 2021 | 2017 |
| HQ | Indianapolis, United States | United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Prim6 at a glance
Prim6 generates $47.4K in revenue with 2 employees, headquartered in Indianapolis, United States.
- Revenue
- $47.4K
- Valuation
- $711.5K
- Funding
- $180K
- Team size
- 2
- Founded
- 2021
Big data intelligence company offering a tokenized blockchain asset management SaaS
Recurpal at a glance
Recurpal generates $45.3K in revenue with 1 employees, headquartered in United States.
- Revenue
- $45.3K
- Team size
- 1
- Founded
- 2017
Helping startups get more out of their SaaS services. Automatically track your unused or unwanted subscriptions. We're always on the lookout for the very best candidates: people who'll happily challenge the status quo, advocate for our…
Other Prim6 alternatives
Prim6 competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Prim6 vs Recurpal: frequently asked questions
Is Prim6 or Recurpal bigger?
Prim6 is the bigger company by revenue, at $47.4K against $45.3K for Recurpal.
How much revenue does Prim6 make?
Prim6 generates $47.4K in annual revenue with a team of 2.
How much revenue does Recurpal make?
Recurpal generates $45.3K in annual revenue with a team of 1.
How much funding has Prim6 raised?
Prim6 has raised $180K in total funding since it was founded in 2021.